MAR 15, 2017 7:40 AM PDT

Glucose and Alzheimer's: Is There a Connection?

Alzheimer’s disease (AD) is well known for its devastating effect on memory and cognition. People who deal with it slowly lose the ability to remember how to perform routine daily tasks. They also slowly lose touch with reality, often not remembering loved ones and family members. The goal of a good amount of research is to understand and recognize early signs of the disease. That is no easy task however. One of the indicators of AD is a decline in glucose levels in the brain. It begins in the early stages of the disease, when there are just small signs on cognitive impairment. This is the problem in AD, the early signs are often chalked up to simple age-related forgetfulness.
It’s not fully clear yet from research whether the decline in brain glucose is a result of AD or a precursor. It’s even been considered as a possible cause but there is no definite research that can determine that yet. A team from the Lewis Katz School of Medicine at Temple University might be on the right track however. A study recently completed by scientists there now shows definite evidence that glucose deprivation in the brain triggers the onset of cognitive decline. It’s especially evident in memory issues.
 
Domenico Praticò, MD, Professor in the Center for Translational Medicine at the Lewis Katz School of Medicine at Temple University (LKSOM) stated in a press release, "In recent years, advances in imaging techniques, especially positron emission tomography (PET), have allowed researchers to look for subtle changes in the brains of patients with different degrees of cognitive impairment. One of the changes that has been consistently reported is a decrease in glucose availability in the hippocampus." It’s been well-established that the hippocampus is the key part of the brain that is active in making and storing memories. And the brain relies on glucose as fuel, so a decline in the levels of glucose in key brain areas is significant in the onset of Alzheimer’s.
 
The study from the team at LKSOM was published online January 31 in the journal Translational Psychiatry. It’s the first study of it’s kind to link memory impairment to glucose deprivation. The mechanism behind this link involves the accumulation of a protein known as phosphorylated tau. Dr. Praticò explained, “Phosphorylated tau precipitates and aggregates in the brain, forming tangles and inducing neuronal death," explained. In general, a greater abundance of neurofibrillary tau tangles is associated with more severe dementia.”
 
The research is also significant because it identifies the protein known as p38 as being a promising drug target for researchers looking at medications to treat Alzheimer’s. Initially neurons activate this protein when glucose in the brain dips, but eventually, the activation of p38 causes the disease to progress quicker because it increases the rate of tau phosphorylation
 
Dr. Praticò's team used a mouse model to investigate memory impairments and glucose levels in the brain. By injecting mice with 2-deoxyglucose (DG) which stops glucose from entering the brain, and the measuring cognitive impairment, it was shown that the glucose deficient mice performed significantly worse than the untreated mice who had normal glucose production. Looking at the brains of the glucose deprived mice further confirmed the hypothesis when researchers saw abnormal synaptic function as well as high levels of cell death an increased amounts of phosphorylated tau. Even in small increments, as happens in diabetes patients, there was a demonstrable effect on cognition, linking the disease of diabetes and it’s accompanying insulin resistance to the progression of Alzheimer’s.
 
The team hopes to continue further work where the protein p38 is inhibited to see if memory impairments can be reversed. Any possible drug targets that come about from this research cold be an “exciting avenue” according to Praticò. The following video explains how the brain uses glucose. While it deals with too much glucose, the lack of glucose is emerging as a concern as well, check it out.
About the Author
  • I'm a writer living in the Boston area. My interests include cancer research, cardiology and neuroscience. I want to be part of using the Internet and social media to educate professionals and patients in a collaborative environment.
You May Also Like
DEC 15, 2019
Microbiology
DEC 15, 2019
Neurons in the Gut Can Detect Salmonella & Protect Against Infection
Nerve cells act as critical sensors for the human body, and now scientists have found that they have another role in the small intestine....
DEC 21, 2019
Drug Discovery & Development
DEC 21, 2019
Magic Mushrooms Pass First Clinical Trial Against Depression
With the efficacy of selective serotonin reuptake inhibitors such as Prozac increasingly coming under question, the search for new pharmaceutical treatment...
DEC 20, 2019
Drug Discovery & Development
DEC 20, 2019
Drug Repurposing May Provide Hope for Deadly Childhood Seizure Disorder
The life-threatening and treatment-resistant seizure disorder among children known as the ‘Dravet Syndrome’ may soon have new safe and effectiv...
JAN 09, 2020
Neuroscience
JAN 09, 2020
Why Do you Have a Higher IQ than your Grandparents?
In the 1980’s James Flynn found that on average, human intelligence quotients (IQ) increase by 3 points every 10 years. Known as the “Flynn eff...
JAN 16, 2020
Cannabis Sciences
JAN 16, 2020
College Kids Exchange Alcohol for Weed in Legal States
Researchers have now found that legalization of marijuana has significantly increased the number of college-aged pot smokers, while significantly decreased...
JAN 20, 2020
Neuroscience
JAN 20, 2020
Ovarian Cancer Protein Accelerates Alzheimer's Neurodegeneration
Around 21,000 people in the US are diagnosed with ovarian cancer every year, while an estimated 5.8 million Americans have Alzheimer’s. Now, research...
Loading Comments...